CORT Earnings
Latest Revenue256.1M
Latest Net Income43.0M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.40 | 256.1M | 43.0M | +31.7% | +21.2% |
| Q1 2026 | -$0.30 | 164.9M | -31761000 | +4.9% | -257.9% |
| Q4 2025 | $0.23 | 202.1M | 24.3M | +11.1% | -20.7% |
| Q3 2025 | $0.19 | 207.6M | 19.7M | +13.7% | -57.8% |
| Q2 2025 | $0.33 | 194.4M | 35.1M | +18.7% | -2.9% |
| Q1 2025 | $0.19 | 157.2M | 20.5M | +7.1% | -29.6% |
| Q4 2024 | $0.29 | 181.9M | 30.7M | +34.3% | -3.3% |
| Q3 2024 | $0.45 | 182.5M | 47.2M | +47.7% | +45.2% |
| Q2 2024 | $0.34 | 163.8M | 35.5M | — | — |
| Q1 2024 | $0.27 | 146.8M | 27.8M | — | — |
| Q4 2023 | $0.30 | 135.4M | 31.4M | — | — |
| Q3 2023 | $0.31 | 123.6M | 31.4M | — | — |
Corcept Therapeutics (CORT) — Earnings